Elevate your CV prevention game. Passionate about CVD prevention? Join the new CVR3 working group to shape the future of care for generations. Contact CaReMe@bcs.com to join the CaReMe UK network. #CVD .#lipids.#triglycerides.#diabetes.#renal.

Breaking news. Introducing the first pragmatic CVD residual risk reduction guideline in the UK. A game changer in addressing CV risk beyond LDL-C, this pathway from a multidisciplinary team in Yorkshire gives practical advice on tackling metabolic, inflammatory, & thrombotic risk

RT @DFCapodanno: Breaking news from Novo Nordisk. In the randomized, double-blind SELECT trial, semaglutide 2.4 mg as an adjunct to standar….

RT @EricTopol: Not every day you see an anti-obesity drug that has an average of >24% body weight loss.🆕 @NEJM #ADA2023 ..

RT @WYHHealthyHeart: Are you working in Primary Care and have involvement in the referrals process to Lipid Clinics? . We've created a surv….

Updated NICE guideline on obesity published today.

RT @parthaskar: A short message to all with #Diabetes about the NICE guidelines released . “Or forever hold your peace” 😊 #gbdoc https://t.….

Encouraging data with SGLT2i continue to build in HFpEF.

RT @drkevinfernando: Finally, I have updated my @GPnotebook diabetes & renal shortcut to reflect new licenses/indications! Given complexit….